HALOZYME THERAPEUTICS INC

Ticker: HALO CUSIP: 40637H109 Class: EQTY

Boston Partners's Holding History (CIK: 0001386060)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 487,069 Value ($000) $33,112 Avg Close $67.27 Range $61.23 - $76.30
Q3 2025
Shares 444,803 Value ($000) $32,082 Avg Close $66.43 Range $51.78 - $79.50
Q2 2025
Shares 449,366 Value ($000) $23,999 Avg Close $56.90 Range $47.50 - $70.51
Q1 2025
Shares 416,325 Value ($000) $26,165 Avg Close $58.09 Range $47.52 - $66.00
Q4 2024
Shares 407,984 Value ($000) $19,955 Avg Close $51.28 Range $42.01 - $62.13
Q3 2024
Shares 571,947 Value ($000) $32,392 Avg Close $57.33 Range $50.68 - $65.53
Q2 2024
Shares 729,147 Value ($000) $38,232 Avg Close $43.86 Range $37.73 - $53.00
Q1 2024
Shares 630,368 Value ($000) $25,500 Avg Close $37.49 Range $33.15 - $42.64
Q4 2023
Shares 552,392 Value ($000) $20,218 Avg Close $37.66 Range $32.83 - $42.82
Q3 2023
Shares 83,415 Value ($000) $3,186 Avg Close $40.96 Range $35.71 - $45.00